Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Italian-based Stevanato Group has signed an agreement with Colanar, a provider of small-batch pharma filling machines.
read more
Kedrion has formed a research partnership with Columbia University Irving Medical Center to develop and test a new IgG therapy for COVID-19.
read more
Catalent will provide development, manufacturing and commercialization services for lenzilumab, Humanigen’s anti-human GM-CSF monoclonal antibody.
read more
Headlands Research announced its research centers have been selected to participate in numerous upcoming COVID-19 vaccine clinical trials.
read more
Lantern Pharma announced agreements with contract manufacturing companies for process development and manufacturing for two of Lantern's oncology drug candidates, LP-300 and LP-184.
read more
The company is now supporting more than 200 of these projects globally.
read more
SCA Pharma plans to expand its sterile pharmaceutical manufacturing facility in Windsor by 40 percent.
read more
Nabriva has entered into an exclusive agreement with subsidiaries of Merck to market, sell and distribute SIVEXTRO in the United States and certain of its territories.
read more
Invivoscribe announces the launch of a fully integrated drug development engine.
read more
Arch Biopartners engaged a global CRO to initiate and conduct a Phase II trial in the U.S. for its lead drug Metablok for COVID-19 complications.
read more
NeuroRx, in partnership with Relief, announced the independent Data Monitoring Committee has reviewed the findings in the first 30 patients treated in Fast Track trials of Aviptadil in patients with Critical COVID-19 with respiratory failure.
read more
Orgenesis it has entered into a Collaboration Agreement with Educell, a European cell therapy company.
read more
Cipla has received final approval for its ANDA for Icatibant Injectable 30mg/3mL from the FDA.
read more
Syneos Health® has signed a new three-year agreement with Pfizer to deliver global product development solutions to support Pfizer's portfolio.
read more
Granules voluntarily recalling 12 lots of Metformin Hydrochloride Extended-Release Tablets due to the detection of NDMA levels above the Acceptable Daily Intake Limit.
read more